Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call PR Newswire RED BANK, N.J., March 13, 2023 RED BANK, N.J., March 13, 2023 /PRNewswire/ -- Provention...
Provention Bio Announces the Grant of Inducement Awards PR Newswire RED BANK, N.J., March 3, 2023 RED BANK, N.J., March 3, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the...
Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 PR Newswire RED BANK, N.J., Feb. 23, 2023 RED BANK, N.J., Feb. 23, 2023 /PRNewswire/ -- Provention...
Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi US PR Newswire RED BANK, N.J., Feb. 13, 2023 Companies collaborating to expand access to TZIELD™...
Provention Bio to Present at the SVB Securities Global Biopharma Conference PR Newswire RED BANK, N.J., Feb. 8, 2023 RED BANK, N.J., Feb. 8, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq:...
Provention Bio Announces the Grant of Inducement Awards PR Newswire RED BANK, N.J., Feb. 3, 2023 RED BANK, N.J., Feb. 3, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company...
Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD® PR Newswire RED BANK, N.J., Feb. 2, 2023 RED BANK, N.J., Feb. 2, 2023...
Provention Bio Announces the Grant of Inducement Awards PR Newswire RED BANK, N.J., January 6, 2023 RED BANK, N.J., January 6, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the...
Provention Bio Announces Appointment of Rita Jain, M.D., to Board of Directors PR Newswire RED BANK, N.J., Jan. 5, 2023 RED BANK, N.J., Jan. 5, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq:...
Provention Bio Announces the Grant of Inducement Awards PR Newswire RED BANK, N.J., Dec. 2, 2022 RED BANK, N.J., Dec. 2, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
